Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.
about
Comparative health systems research among Kaiser Permanente and other integrated delivery systems: a systematic literature review.Collaborative cardiac care service: a multidisciplinary approach to caring for patients with coronary artery diseaseCharacteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disordersA centralized cardiovascular risk service to improve guideline adherence in private primary care offices.A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.Evolution of Clinical Pharmacy in the USA and Future Directions for Patient CareAmbulatory treatment gaps in patients with ischemic stroke or transient ischemic attack.The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.Factors associated with recurrent coronary events among patients with cardiovascular disease.Reduced health care expenditures after enrollment in a collaborative cardiac care service.
P2860
Q33975732-781AAE27-7595-4E56-9A8E-540C4CDD6CE8Q34566413-4634A80D-A280-4619-8BE2-E77333EF5130Q35649045-83CE1145-D245-4B32-94B7-1B0CDBDB642DQ35908853-8F12E09D-EB80-433E-909C-7B772FFDB533Q36390773-A8E80592-03C8-453B-A5D9-0EF89D8665C5Q36767799-E1271994-0269-4655-B172-65B9BD0C2653Q37197594-7930C549-A120-4179-8AC4-EC87502066EBQ37850830-818CE3C5-C6C8-44A5-A4A3-224ECB1B2D8BQ44758312-7C94CFF6-EB27-4640-8432-A654DB3CCADBQ51535949-8BB96C65-D688-48B3-8276-49437EF12147
P2860
Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Mortality reduction benefits o ...... usive coronary artery disease.
@en
Mortality reduction benefits o ...... usive coronary artery disease.
@nl
type
label
Mortality reduction benefits o ...... usive coronary artery disease.
@en
Mortality reduction benefits o ...... usive coronary artery disease.
@nl
prefLabel
Mortality reduction benefits o ...... usive coronary artery disease.
@en
Mortality reduction benefits o ...... usive coronary artery disease.
@nl
P2093
P2860
P356
P1433
P1476
Mortality reduction benefits o ...... usive coronary artery disease.
@en
P2093
Clinical Pharmacy Cardiac Risk Service Study Group
David G Ward
Dennis K Helling
John A Merenich
Jon Rasmussen
Kari L Olson
Thomas Delate
P2860
P304
P356
10.1592/PHCO.27.10.1370
P407
P577
2007-10-01T00:00:00Z